![]() |
![]() |
||||||||||||||||||
| Latest News | |||||||||||||||||||
|
Mauritius-origin Cynomolgus NHPs Now Available from SNBL USAAlice, TX – July 31, 2009 – SNBL USA, one of the nation’s leading preclinical testing companies, is announcing the immediate availability of captive bred Mauritius-origin nonhuman primates (NHPs) through its Texas facility, SNBL USA Scientific Resource Center (SNBL USA SRC). Since its opening in July 2007, SNBL USA SRC continues to meet the industry’s on-going demand for the availability of high quality primates. As one of the few providers of Mauritian cynos, SNBL USA is pleased to offer our naturally, B-virus free Mauritians for clients’ research requirements, including study placements and/or acquisition for your own research needs. Benefits of SNBL USA’s Mauritius-origin animals:
SNBL USA continues to broaden its services and products portfolio while at the same time leveraging our core strengths, NHP research, and building (not reducing) a competent, knowledgeable team. SNBL USA remains in a great position to provide what SNBL USA clients are seeking - accessibility to quality test systems and preclinical research support that will in turn, help facilitate innovative science into life-changing therapies. About SNBL USA, Ltd. Headquartered in Everett, WA, SNBL USA, Ltd. is a preclinical CRO that specializes in nonhuman primate (NHP) and small animal research. Study programs range from regulatory toxicology to customized study designs and disease models. Specialized programs include reproductive toxicology, safety pharmacology, immunotoxicology and carcinogenicity. SNBL USA SRC complements SNBL USA in providing quality NHP resources. Through a commitment to investment and excellence, SNBL USA strives to offer the biotechnology and pharmaceutical industries unparalleled quality in both science and service. If you are interested in SNBL USA or SNBL USA SRC, please contact us at (425) 407-0121 or info@snblusa.com |
![]() |
|||||||||||||||||